1. Home
  2. NRIX vs PRGO Comparison

NRIX vs PRGO Comparison

Compare NRIX & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

N/A

Current Price

$15.62

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Logo Perrigo Company plc

PRGO

Perrigo Company plc

N/A

Current Price

$9.42

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NRIX
PRGO
Founded
2009
1887
Country
United States
Ireland
Employees
357
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
2.0B
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
NRIX
PRGO
Price
$15.62
$9.42
Analyst Decision
Strong Buy
Buy
Analyst Count
13
3
Target Price
$29.46
$19.33
AVG Volume (30 Days)
690.4K
3.2M
Earning Date
05-01-2026
05-29-2026
Dividend Yield
N/A
11.82%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$76,987,000.00
$800,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$26.32
$1.02
P/E Ratio
N/A
N/A
Revenue Growth
99.31
N/A
52 Week Low
$8.18
$9.70
52 Week High
$22.50
$29.08

Technical Indicators

Market Signals
Indicator
NRIX
PRGO
Relative Strength Index (RSI) 45.34 16.79
Support Level $15.62 N/A
Resistance Level $16.47 $14.84
Average True Range (ATR) 0.80 0.64
MACD 0.09 -0.40
Stochastic Oscillator 57.14 2.97

Price Performance

Historical Comparison
NRIX
PRGO

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

About PRGO Perrigo Company plc

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Share on Social Networks: